PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
CareSourceMedicaid · Coverage · Medical Policy · OH · Pathology, Internal Medicine, Family Medicine +11 moreHigh impact

[Ohio] Avalon Q3 Policy Update - February 2025

Act
by Mar 31, 2025
Effective date
Apr 1, 2025
Identified
May 9, 2026

Summary

CareSource (Ohio Medicaid and Ohio MyCare) is implementing updated laboratory benefit management policies through Avalon Healthcare Solutions effective April 1, 2025. The update affects 40+ laboratory testing policies covering routine testing management (RTM), a post-service pre-payment clinical claim editing program. Providers must ensure all laboratory claims comply with the updated Avalon policies, which are available on Avalon's website.

Get alerts when payers change rules like this one

We check CareSource and other payers every day and email you when a change matches your specialty and state.

Get CareSource alertsPolicy Monitoring is free. No card required.

What to do

by Mar 31, 2025 · 5 steps
01Billing team and providers must review all 40+ updated laboratory policies on Avalon Healthcare Solutions website (https://www.avalon-healthcare.com or through CareSource Provider Portal).
02Immediately register and test claims using the Trial Claim Advice Tool on the CareSource Provider Portal to simulate compliance with new policies before April 1, 2025.
03Update laboratory ordering procedures and billing workflows to ensure claims for Flow Cytometry, Cervical Cancer Screening, Prostate Biopsy Analysis, Prenatal Screening, Hepatitis Testing, Celiac Disease Testing, Thyroid Testing, Alzheimer biomarkers, Cardiovascular Risk Assessment, Bone Turnover Markers, Breast Cancer Risk Assessment, Fecal Analysis, TB Testing, Chemoresistance Assays, Therapeutic Antibody Monitoring, Hepatic Fibrosis Testing, Oral Cancer Screening, Thiopurine Metabolites, Influenza Diagnostics, IBD Testing, Multiple Sclerosis Biomarkers, Tumor Markers, Pathogen Panels, Cardiac Biomarkers, TBI Testing, Pancreatic Enzymes, Folate Testing, Inflammation Testing, Urine Culture, Vector-Borne Infections, Beta-Hemolytic Streptococcus, Gamma-glutamyl Transferase, Thrombosis Risk Testing, Alpha-1 Antitrypsin, Microorganism Identification, and Nerve Fiber Density Testing comply with Avalon's clinical editing criteria.
04Failure to comply will result in claim denials or payment delays post-service.
05Communicate policy changes to all providers ordering laboratory tests.

Original notice

[Ohio] Avalon Q3 Policy Update - February 2025
caresource.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account